Literature DB >> 23461686

Diagnosing epidermolysis bullosa type and subtype in infancy using immunofluorescence microscopy: the Stanford experience.

David R Berk1, Leila Jazayeri, M Peter Marinkovich, Uma N Sundram, Anna L Bruckner.   

Abstract

The natural history of inherited epidermolysis bullosa (EB) varies significantly across subtypes. When confronted with an infant suspected to have EB, rapidly determining the type and subtype is critical in counselling families accurately about the infant's diagnosis and prognosis. Although transmission electron microscopy (TEM) has been considered the criterion standard for EB diagnosis, immunofluorescence microscopy (IFM) using monoclonal antibodies (mAbs) to EB-specific basement membrane zone proteins has several advantages, but few studies have evaluated the diagnostic utility of IFM. We sought to evaluate the clinical utility of IFM using an expanded panel of EB-specific mAbs. This was a retrospective review of pathology reports from infants younger < 1 year old with suspected EB primarily analyzed with IFM by the Stanford Dermatopathology service. Seventy-seven cases were identified for analysis, of which 20 were suboptimal for IFM analysis. Fifty-five cases were diagnosed with EB and classified as follows: EB simplex (n = 5), junctional EB (n = 31), dystrophic EB (n = 19). TEM was available in 36 of 55 cases (65%). IFM with an expanded panel of EB-specific mAbs should be considered the first-line diagnostic test to evaluate infants with clinically suspected EB.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23461686     DOI: 10.1111/j.1525-1470.2012.01880.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  4 in total

1.  Somatic correction of junctional epidermolysis bullosa by a highly recombinogenic AAV variant.

Authors:  Sandra P Melo; Leszek Lisowski; Elizaveta Bashkirova; Hanson H Zhen; Kirk Chu; Douglas R Keene; M Peter Marinkovich; Mark A Kay; Anthony E Oro
Journal:  Mol Ther       Date:  2014-01-06       Impact factor: 11.454

2.  Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa.

Authors:  C Has; L Liu; M C Bolling; A V Charlesworth; M El Hachem; M J Escámez; I Fuentes; S Büchel; R Hiremagalore; G Pohla-Gubo; P C van den Akker; K Wertheim-Tysarowska; G Zambruno
Journal:  Br J Dermatol       Date:  2019-08-09       Impact factor: 9.302

3.  Utility of Immunofluorescence Antigen Mapping in Hereditary Epidermolysis Bullosa.

Authors:  Raghavendra Rao; Varsha M Shetty
Journal:  Indian J Dermatol       Date:  2021 Jul-Aug       Impact factor: 1.494

4.  Wound closure in epidermolysis bullosa: data from the vehicle arm of the phase 3 ESSENCE Study.

Authors:  Dedee F Murrell; Amy S Paller; Christine Bodemer; John Browning; Milos Nikolic; Jay A Barth; Hjalmar Lagast; Eva Krusinska; Allen Reha
Journal:  Orphanet J Rare Dis       Date:  2020-07-21       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.